As per the research report, the size of the Asia Pacific Adhesion Barrier Market was valued at USD 168.19 million in 2021 and estimated to be growing at a CAGR of 10.1%, to reach USD 272.10 million by 2026.
The region's demand for better healthcare facilities, medical devices, and technologies is being driven by a rapidly growing geriatric population, an epidemiological shift from infectious to chronic diseases, increased life expectancy, the expansion of private-sector hospitals in these areas, and an increased demand for surgical interventions. Because there are no alternative medications available for surgical adhesion prevention, using adhesion barriers is an effective way to reduce or avoid the occurrence, severity, extent, and consequences of post-surgical adhesions. Adhesive barriers are the only option for post-surgical adhesions, which is projected to increase demand for them throughout the forecast period. The use of adhesion barriers is becoming more common as the number of surgical operations grows. Growing awareness about the usage of adhesion barriers after surgery in the Asia Pacific region is expected to fuel demand for adhesion barriers and, as a result, contribute to market development during the forecast period.
The APAC Adhesion Barrier Market is expected to be hampered by the restricted uses of a few product types of adhesion barriers and the high cost of surgeries.
The growing need for and availability of adhesion barriers for use in abdominal, gynecologic, orthopedic, cardiovascular, reconstructive, and urological procedures is likely to provide huge growth opportunities for APAC Adhesion barrier manufacturers. The expansion of this market is being fueled by an increase in the number of surgeries and sports-related injuries, as well as an increase in the elderly population and increased awareness of adhesion formation and related diseases.
The growing disease burden and amount of surgical procedures performed in this region are likely to provide growth opportunities for adhesion barrier market players. Because of the serious consequences of post-surgery adhesions in patients, the market for treatments like adhesion barriers is growing. In addition, as the number of surgeries performed in the APAC region rises, the relevance of these products will expand in the future years.
With the increased risk of post-operative adhesion, however, the industry continues to face challenges in terms of accessibility, health education, and awareness of the importance of treatment. New adhesion barriers need significant investment, and new products often take more than 7–8 years to gain marketing approval. The cost and time it takes for a product to undergo clinical trials and then pass those tests is extremely expensive, with just a small possibility of the product receiving approval.
This research report on the Asia Pacific Adhesion Barrier Market has been segmented and sub-segmented into the following categories:
By Product Form:
By Surgical Application:
The adhesion barrier market in APAC is expected to develop at the quickest rate during the forecast period, owing to rising medical tourism and an ageing population that is more vulnerable to injuries and fractures, all of which lead to a rise in the number of surgeries. Furthermore, major firms are investing in the region's undeveloped market as part of their business strategy, resulting in the region's fastest development. Due to the expanding elderly population and increasing prevalence of cardiac and neurosurgery, which necessitate surgical treatments, Asia-Pacific is expected to surpass all other areas by recording the greatest CAGR from 2021 to 2026.
Furthermore, the market in the area is expected to be driven by increased private sector investment in healthcare and quickly developing medical tourism. Due to its enormous population and developing healthcare industry, Asia Pacific is the most lucrative healthcare market. With a large and expanding population, the total disease prevalence in nations like China and India is increasing at an alarming rate.
The Top companies leading in the APAC Adhesion Barrier Market profiled in the report are Baxter International Inc., Medtronic Plc., C. R. Bard, Inc., Johnson & Johnson, Sanofi Group, Atrium Medical Corporation, Integra Lifesciences Corporation, Anika Therapeutics Inc., FzioMed, Inc., and MAST Biosurgery AG.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Synthetic Adhesion Barriers
184.108.40.206 Regenerated Cellulose
220.127.116.11 Hyaluronic Acid
18.104.22.168 Polythene Glycol
5.1.3 Natural Adhesion Barriers
22.214.171.124 Collagen & Protein
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Product Form
5.2.2 Film Adhesion Barriers
5.2.3 Gel Adhesion Barriers
5.2.4 Liquid Adhesion Barriers
5.2.5 Y-o-Y Growth Analysis, By Product Form
5.2.6 Market Attractiveness Analysis, By Product Form
5.2.7 Market Share Analysis, By Product Form
5.3 Surgical Applications
5.3.2 Gynaecological Surgeries
5.3.3 Cardiovascular Surgeries
5.3.4 Neurological Surgeries
5.3.5 Orthopaedic Surgeries
5.3.6 General/Abdominal Surgeries
5.3.7 Urological Surgeries
5.3.8 Reconstructive Surgeries
5.3.9 Other Surgeries
5.3.10 Y-o-Y Growth Analysis, By Surgical Applications
5.3.11 Market Attractiveness Analysis, By Surgical Applications
5.3.12 Market Share Analysis, By Surgical Applications
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Product Form
220.127.116.11 By Surgical Applications
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Product Form
188.8.131.52 By Surgical Applications
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Product Form
22.214.171.124 By Surgical Applications
6.6 South Korea
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Baxter International Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic Plc.
8.3 C. R. Bard, Inc.
8.4 Johnson & Johnson
8.5 Sanofi Group
8.6 Atrium Medical Corporation
8.7 Integra Lifesciences Corporation
8.8 Anika Therapeutics Inc.
8.9 FzioMed, Inc.
8.10 MAST Biosurgery AG
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures